PROSPER Study

Next to the evolutionary control of human life span, we have studied specific determinants of disease in old age. In sharp contrast to general expectation, it appeared that our knowledge on risk factors of disease at middle age cannot always be extrapolated to old age. Amongst others, we have shown that a high levels of total cholesterol do not have detrimental effects, whereas low thyroid function appears to be beneficial. The finding on cholesterol prompted us to perform an unprecedented large randomized controlled trial in elderly people (PROSPER) to test the hypothesis that cholesterol lowering drugs have clinical benefit.

For information on the PROSPER Study you can contact Dr. S. Trompet

More information on the PROSPER Study can be found at  LangLeven.net/Prosper Studie (only available in Dutch)